Several recent studies have shown that CA XII is an attractive and potential target for tumour treatment and diagnostic intervention, especially for hypoxic tumours that are resistant to traditional radiotherapy and chemotherapy [9,10,11]. This evidence concerns the gene CA12 and neoplasm.